- Author: Chakri Yarlagadda, MD, FACC, FSCAI, FASNC, CCDS; Chief Editor: Richard A Lange, MD, MBA more...
Cardiac tamponade is a clinical syndrome caused by the accumulation of fluid in the pericardial space, resulting in reduced ventricular filling and subsequent hemodynamic compromise. The condition is a medical emergency, the complications of which include pulmonary edema, shock, and death.
Signs and symptoms
Symptoms vary with the acuteness and underlying cause of the tamponade. Patients with acute tamponade may present with dyspnea, tachycardia, and tachypnea. Cold and clammy extremities from hypoperfusion are also observed in some patients. Other symptoms may include the following:
Elevated jugular venous pressure
See Clinical Presentation for more detail.
Prompt diagnosis is key to reducing the mortality risk for patients with cardiac tamponade. Although echocardiography provides useful information, cardiac tamponade is a clinical diagnosis. Echocardiography can be used to visualize ventricular and atrial compression abnormalities as blood cycles through the heart. The following may be observed with 2-dimensional (2-D) echocardiography:
An echo-free space posterior and anterior to the left ventricle and behind the left atrium
Early diastolic collapse of the right ventricular free wall
Late diastolic compression/collapse of the right atrium
Swinging of the heart in its sac
Inferior vena cava plethora with minimal or no collapse with inspiration
A greater than 40% relative inspiratory augmentation of right-side flow
A greater than 25% relative decrease in inspiratory flow across the mitral valve
See Workup for more detail.
Removal of pericardial fluid is the definitive therapy for tamponade and can be done using the following three methods:
Emergency subxiphoid percutaneous drainage
Echocardiographically guided pericardiocentesis
Percutaneous balloon pericardiotomy
The role of medication therapy in cardiac tamponade is limited.
Cardiac tamponade is a clinical syndrome caused by the accumulation of fluid in the pericardial space, resulting in reduced ventricular filling and subsequent hemodynamic compromise. The condition is a medical emergency, the complications of which include pulmonary edema, shock, and death. (See Pathophysiology, Etiology, and Prognosis.)
The overall mortality risk depends on the speed of diagnosis, the treatment provided, and the underlying cause of the tamponade. Untreated, the condition is rapidly and universally fatal (see the image below). (See Presentation, Workup, Treatment, and Medication.)
The pericardium, which is the membrane surrounding the heart, is composed of 2 layers. The thicker parietal pericardium is the outer fibrous layer; the thinner visceral pericardium is the inner serous layer. The pericardial space normally contains 20-50mL of fluid.
Reddy et al describe 3 phases of hemodynamic changes in tamponade, as follows :
Phase I - The accumulation of pericardial fluid causes increased stiffness of the ventricle, requiring a higher filling pressure; during this phase, the left and right ventricular filling pressures are higher than the intrapericardial pressure
Phase II - With further fluid accumulation, the pericardial pressure increases above the ventricular filling pressure, resulting in reduced cardiac output (see the Cardiac Output calculator)
Phase III - A further decrease in cardiac output occurs, which is due to the equilibration of pericardial and left ventricular (LV) filling pressures
Pericardial effusions, which cause cardiac tamponade, can be serous, serosanguineous, hemorrhagic, or chylous.
The underlying process for the development of tamponade is a marked reduction in diastolic filling, which results when transmural distending pressures become insufficient to overcome increased intrapericardial pressures. Tachycardia is the initial cardiac response to these changes to maintain the cardiac output.
Systemic venous return is also altered during tamponade. Because the heart is compressed throughout the cardiac cycle due to the increased intrapericardial pressure, systemic venous return is impaired and right atrial and right ventricular collapse occurs. Because the pulmonary vascular bed is a vast and compliant circuit, blood preferentially accumulates in the venous circulation, at the expense of LV filling. This results in reduced cardiac output and venous return.
The amount of pericardial fluid needed to impair diastolic filling of the heart depends on the rate of fluid accumulation and the compliance of the pericardium. Rapid accumulation of as little as 150mL of fluid can result in a marked increase in pericardial pressure and can severely impede cardiac output, whereas 1000 mL of fluid may accumulate over a longer period without any significant effect on diastolic filling of the heart. This is due to adaptive stretching of the pericardium over time. A more compliant pericardium can allow considerable fluid accumulation over a longer period without hemodynamic insult.
For all patients, malignant diseases are the most common cause of pericardial tamponade. Among etiologies for tamponade, Merce et al reported the following incidence rates:
Malignant diseases - 30-60% of cases
Uremia - 10-15% of cases
Idiopathic pericarditis - 5-15%
Infectious diseases - 5-10%
Anticoagulation - 5-10%
Connective tissue diseases - 2-6%
Dressler or postpericardiotomy syndrome - 1-2%
Human immunodeficiency virus (HIV) infection
Infection - Viral, bacterial (tuberculosis), fungal
Drugs - Hydralazine, procainamide, isoniazid, minoxidil
Postcoronary intervention - Ie, coronary dissection and perforation
Postcardiac percutaneous procedures - Including mitral valvuloplasty, atrial septal defect (ASD) closure, left atrial appendage occlusion
Trauma to the chest
Cardiovascular surgery - Postoperative pericarditis 
Postmyocardial infarction - Free wall ventricular rupture, Dressler syndrome
Connective tissue diseases - Systemic lupus erythematosus, rheumatoid arthritis, dermatomyositis
Radiation therapy to the chest
Iatrogenic  - After sternal biopsy, transvenous pacemaker lead implantation, pericardiocentesis, or central line insertion
Complication of surgery at the esophagogastric junction - Eg, antireflux surgery
Pneumopericardium - Due to mechanical ventilation or gastropericardial fistula
Duchenne muscular dystrophy
Type A aortic dissection
Occurrence in the United States
The incidence of cardiac tamponade is 2 cases per 10,000 population in the United States. Approximately 2% of penetrating injuries are reported to result in cardiac tamponade.
Sex- and age-related demographics
In children, cardiac tamponade is more common in boys than in girls, with a male-to-female ratio of 7:3. In adults, cardiac tamponade appears to be slightly more common in men than in women. A male-to-female ratio of 1.25:1 was observed at the author's referral center, based on the International Classification of Diseases (ICD) code 423.9. However, a male-to-female ratio of 1.7:1 was observed at another level 1 trauma center.
Cardiac tamponade related to trauma or HIV is more common in young adults, whereas tamponade due to malignancy and/or renal failure occurs more frequently in elderly individuals.
Cardiac tamponade is a medical emergency. The prognosis depends on prompt recognition and management of the condition and the underlying cause of the tamponade. Untreated, cardiac tamponade is rapidly and universally fatal.
Haneya et al retrospectively (2005-2011) evaluated the impact of timing and indication of reexploration for bleeding or tamponade following cardiac surgery in 209 patients and found that reexploration was associated with higher rates of mortality and morbidity. Multivariate analysis indicated it was the adverse effects of reexploration (eg, blood loss, transfusion requirements) rather than the procedure itself that were independent risk factors for death. Adverse outcomes were more likely in those whose reexploration was delayed and who suffered from cardiac tamponade.
In a separate study, Le et al indicated that following cardiac surgery, there is no advantage for the use of multiple mediastinal chest tubes over a single chest tube in preventing return to the operating room for bleeding or tamponade.
In addition to treatment for the tamponade, all patients should also receive treatment for the condition’s underlying cause in order to prevent recurrence.
In a study of patients with cardiac tamponade, Cornily et al reported a 1-year mortality rate of 76.5% in patients whose tamponade was caused by malignant disease, compared with 13.3% in patients with no malignant disease. The investigators also noted a median survival of 150 days in patients with malignant disease.
Reddy PS, Curtiss EI, Uretsky BF. Spectrum of hemodynamic changes in cardiac tamponade. Am J Cardiol. 1990 Dec 15. 66(20):1487-91. [Medline].
Saito Y, Donohue A, Attai S, Vahdat A, Brar R, Handapangoda I, et al. The syndrome of cardiac tamponade with "small" pericardial effusion. Echocardiography. 2008 Mar. 25(3):321-7. [Medline].
Parvez N, Carpenter JL. Cardiac tamponade in Still disease: a review of the literature. South Med J. 2009 Aug. 102(8):832-7. [Medline].
Ernst E, Zhang J. Cardiac tamponade caused by acupuncture: a review of the literature. Int J Cardiol. 2011 Jun 16. 149(3):287-9. [Medline].
Rylski B, Siepe M, Schoellhorn J, et al. Endoscopic treatment for delayed cardiac tamponade. Eur J Cardiothorac Surg. 2009 Sep 17. [Medline].
Holmes DR Jr, Nishimura R, Fountain R, et al. Iatrogenic pericardial effusion and tamponade in the percutaneous intracardiac intervention era. JACC Cardiovasc Interv. 2009 Aug. 2(8):705-17. [Medline].
Haneya A, Diez C, Kolat P, et al. Re-exploration for bleeding or tamponade after cardiac surgery: impact of timing and indication on outcome. Thorac Cardiovasc Surg. 2015 Feb. 63(1):51-7. [Medline].
Le J, Buth KJ, Hirsch GM, Légaré JF. Does more than a single chest tube for mediastinal drainage affect outcomes after cardiac surgery?. Can J Surg. 2015 Feb 1. 58(1):006814-6814. [Medline].
Cornily JC, Pennec PY, Castellant P, Bezon E, Le Gal G, Gilard M, et al. Cardiac tamponade in medical patients: a 10-year follow-up survey. Cardiology. 2008. 111(3):197-201. [Medline].
Lee YM, Kim HJ, Lee JE, et al. Cardiac tamponade following insertion of an internal jugular vein catheter for hemodialysis. Clin Nephrol. 2009 Sep. 72(3):220-3. [Medline].
Roy CL, Minor MA, Brookhart MA, Choudhry NK. Does this patient with a pericardial effusion have cardiac tamponade?. JAMA. April 2007. 297(16):9. [Medline].
Ikematsu Y. Incidence and characteristics of dysphoria in patients with cardiac tamponade. Heart Lung. 2007 Nov-Dec. 36(6):440-9. [Medline].
Sagristà-Sauleda J, Angel J, Sambola A, Alguersuari J, Permanyer-Miralda G, Soler-Soler J. Low-pressure cardiac tamponade: clinical and hemodynamic profile. Circulation. 2006 Aug 29. 114(9):945-52. [Medline].
Busko, M. ESC Group Issues Triage Strategy to Manage Cardiac Tamponade. Medscape Medical News. Accessed July 21, 2014.
Ristic AD, Imazio M, Adler Y, et al. Triage strategy for urgent management of cardiac tamponade: A position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J 2014; DOI:10.1093/eurheartj/ehu217.
Towbin R. The bowed catheter sign: a risk for pericardial tamponade. Pediatr Radiol. 2008 Mar. 38(3):331-5. [Medline].
Gold MM, Spindola-Franco H, Jain VR, Spevack DM, Haramati LB. Coronary sinus compression: an early computed tomographic sign of cardiac tamponade. J Comput Assist Tomogr. 2008 Jan-Feb. 32(1):72-7. [Medline].
Stone MK, Bauch TD, Rubal BJ. Respiratory changes in the pulse-oximetry waveform associated with pericardial tamponade. Clin Cardiol. 2006 Sep. 29(9):411-4. [Medline].
Boltwood C, Rieders D, Gregory KW. Inspiratory tracking sign in pericardial disease. Circulation. 1984. (suppl II) 70:103.
Petcu DP, Petcu C, Popescu CF, Bataiosu C, Alexandru D. Clinical and cytological correlations in pericardial effusions with cardiac tamponade. Rom J Morphol Embryol. 2009. 50(2):251-6. [Medline].
Sagristà-Sauleda J, Angel J, Sambola A, Permanyer-Miralda G. Hemodynamic effects of volume expansion in patients with cardiac tamponade. Circulation. 2008 Mar 25. 117(12):1545-9. [Medline].
Motas C, Motas N, Rus O, Horvat T. Left paraxiphoidian approach for drainage of pericardial effusions. Interact Cardiovasc Thorac Surg. 2010 Jan. 10(1):4-5. [Medline].
Monaco F, Barone M, David A, et al. [Cardiac tamponade: a modified video-assisted thoracoscopic approach]. Chir Ital. 2009 May-Jun. 61(3):321-6. [Medline].